Non-Invasive Blood Glucose Monitoring System Market (By Technology: Spectroscopy, Electromagnetic, Microwave, Ultrasonic, Thermal, Others; By End User: Hospitals, Homecare, Clinics; By Modality: Non wearable, Wearable, Invasive, Non-invasive; By Distribution Channel: Retail sales, Institutional sales) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Non-Invasive Blood Glucose Monitoring System Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Non-Invasive Blood Glucose Monitoring System Market, by Technology, 2024-2034
8.1.1. Spectroscopy
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Electromagnetic
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Microwave
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Ultrasonic
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Thermal
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2034)
9.1. Non-Invasive Blood Glucose Monitoring System Market, by End User, 2024-2034
9.1.1. Others
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Homecare
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Homecare
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. Non-Invasive Blood Glucose Monitoring System Market, by Modality, 2024-2034
10.1.1. Homecare
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Homecare
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Invasive
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Non-invasive
10.1.4.1. Market Revenue and Forecast (2021-2034)
11.1. Non-Invasive Blood Glucose Monitoring System Market, by Distribution Channel, 2024-2034
11.1.1. Retail sales
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Institutional sales
11.1.2.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2021-2034)
12.1.2. Market Revenue and Forecast, by End User (2021-2034)
12.1.3. Market Revenue and Forecast, by Modality (2021-2034)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.1.5.2. Market Revenue and Forecast, by End User (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.1.6.2. Market Revenue and Forecast, by End User (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.2. Market Revenue and Forecast, by End User (2021-2034)
12.2.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.5.2. Market Revenue and Forecast, by End User (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.6.2. Market Revenue and Forecast, by End User (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.7.2. Market Revenue and Forecast, by End User (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Technology (2021-2034)
12.2.8.2. Market Revenue and Forecast, by End User (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Modality (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.2. Market Revenue and Forecast, by End User (2021-2034)
12.3.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.5.2. Market Revenue and Forecast, by End User (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.6.2. Market Revenue and Forecast, by End User (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.7.2. Market Revenue and Forecast, by End User (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Technology (2021-2034)
12.3.8.2. Market Revenue and Forecast, by End User (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Modality (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.2. Market Revenue and Forecast, by End User (2021-2034)
12.4.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.5.2. Market Revenue and Forecast, by End User (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.6.2. Market Revenue and Forecast, by End User (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.7.2. Market Revenue and Forecast, by End User (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Technology (2021-2034)
12.4.8.2. Market Revenue and Forecast, by End User (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Modality (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.5.2. Market Revenue and Forecast, by End User (2021-2034)
12.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Technology (2021-2034)
12.5.5.2. Market Revenue and Forecast, by End User (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Modality (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Technology (2021-2034)
12.5.6.2. Market Revenue and Forecast, by End User (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Modality (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Medtronic plc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. F. Hoffmann-La Roche Ltd.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Ascensia Diabetes Care
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Dexcom, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Sanofi Novo Nordisk
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Abbott
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Ypsomed Holdings
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Glysens Incorporated
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample